All the events here are relevant to people working in dementia research. If you would like to add your own you can submit an event
- This event has passed.
NAMs Technology Partn3Ring webinar
April 22 @ 2:00 pm - 3:15 pm
The first NAMs webinar will include presentations from researchers working across invertebrate models as partial replacements for the use of mammals, human-relevant microphysiological models, drug efficacy and drug/consumer product toxicity testing.
Early drug screening with C. elegans: A 3Rs-aligned approach
Sara Leighton (Magnitude Biosciences Limited)
• High-throughput C. elegans platform, delivering scalable and predictive insights on drug efficacy, safety and mechanism of action.
• Seeking collaborators to further qualify screening platform and provide access to comparator datasets.
From model to method: Validating C. elegans-based DART assay towards regulatory use
Eva Martini (Nagi Bioscience)
• Providing human relevant whole organism toxicity data that can replace early mammalian screens.
• Seeking collaborators for new toxicology use cases, cross‑species comparison, and standardisation towards regulatory readiness.
Title TBC
Margaret Magdesian (Ananda Devices)
• Developing human iPSC‑based neuro and neuromuscular assays towards replacing animal use in neurotoxicity assays.
• Seeking partners to benchmark and expand applications, including exploring incorporation into regulatory workflows.
Title TBC
Vitaliy Khutoryanskiy (University of Reading)
• Developing invertebrate assays that can replace early-stage mammalian studies in toxicity, irritation, infection and formulation screening.
• Seeking collaborators interested in co-developing and qualifying the invertebrate-based assays for broader application and increased translational relevance.
Register